The Board of Directors of Pharmesis International Ltd. announced the board changes with effect from 15 January 2015: Mr. Chew Heng Ching has relinquished his position as the Chairman of the company and he has been appointed as the Lead Independent Director of the company and the Chairman of Nominating Committee; Mr. Jiang Yun has been appointed as the Executive Chairman of the company and a member of Nominating Committee; Mr. Chew Thiam Keng has relinquished his position as the Chairman of Nominating Committee and he has been appointed as the Chairman of Remuneration Committee; Dr. Pu Weidong has relinquished his position as the Chairman of Remuneration Committee and he has been appointed as a member of Nominating Committee; and Mr. Wu Xuedan has relinquished his position as a member of Nominating Committee. Following the abovementioned changes, with effect from 15 January 2015, the Board of Directors comprises the following members: Mr. Jiang Yun, Executive Chairman; Mr. Wu Xuedan, Executive Director and Chief Executive Officer; Mr. Chew Heng Ching, Lead Independent Director; Mr. Chew Thiam Keng, Independent Non-Executive Director; and Dr. Pu Weidong, Independent Non-Executive Director; Consequent to the above changes, with effect from 15 January 2015, the Board Committees had been re-constituted as: Audit Committee: Mr. Chew Heng Ching (Chairman), Mr. Chew Thiam Keng and Dr. Pu Weidong; Remuneration Committee: Mr. Chew Thiam Keng (Chairman), Mr. Chew Heng Ching and Dr. Pu Weidong; Nominating Committee: Mr. Chew Heng Ching (Chairman), Mr. Chew Thiam Keng, Dr. Pu Weidong and Mr. Jiang Yun.